{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:45:44Z","timestamp":1771652744589,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s11255-016-1419-4","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T16:30:19Z","timestamp":1474907419000},"page":"91-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist\u2019s perspective"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8562-7977","authenticated-orcid":false,"given":"\u00c1gnes","family":"Haris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szilveszter","family":"Dolgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1lm\u00e1n","family":"Polner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"key":"1419_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1440-1797.2009.01101.x","volume":"14","author":"D Jayne","year":"2009","unstructured":"Jayne D (2009) Review article: progress of treatment in ANCA-associated vasculitis. Nephrology 14:42\u201348","journal-title":"Nephrology"},{"key":"1419_CR2","first-page":"253","volume":"6","author":"S Hamour","year":"2010","unstructured":"Hamour S, Salama AD, Pusey CD (2010) Management of ANCA-associated vasculitis: current trends and future prospects. Ther Clin Risk Manag 6:253\u2013264","journal-title":"Ther Clin Risk Manag"},{"key":"1419_CR3","first-page":"233","volume":"20","author":"RJ Falk","year":"2000","unstructured":"Falk RJ, Nachman PH, Hogan SL, Jennette JC (2000) ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin Nephrol 20:233\u2013243","journal-title":"Semin Nephrol"},{"key":"1419_CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hci015","volume":"98","author":"SE Lane","year":"2005","unstructured":"Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: clinical features and mortality. Q J Med 98:97\u2013111","journal-title":"Q J Med"},{"key":"1419_CR5","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","volume":"30","author":"RA Watts","year":"2015","unstructured":"Watts RA, Mahr A, Mohammad AJ et al (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30:i14\u2013i22","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/rheumatology\/keh522","volume":"44","author":"L Harpel","year":"2005","unstructured":"Harpel L, Savage CO (2005) ANCA-associated renal vasculitis at the end of the twentieth century\u2014a disease of older patients. Rheumatology 44:495\u2013501","journal-title":"Rheumatology"},{"key":"1419_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jenette","year":"1994","unstructured":"Jenette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"1419_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revisited international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"1419_CR9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","volume":"9","author":"KWA Westman","year":"1998","unstructured":"Westman KWA, Bygren PG, Olsson H et al (1998) Relapse rate, renal survival, and cancer morbidity in patients with Wegener\u2019s granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9:842\u2013852","journal-title":"J Am Soc Nephrol"},{"key":"1419_CR10","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","volume":"64","author":"S Lionaki","year":"2012","unstructured":"Lionaki S, Blyth ER, Hogan SL et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides. Arthritis Rheum 64:3452\u20133462","journal-title":"Arthritis Rheum"},{"key":"1419_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-0031-1279830","volume":"32","author":"A Casian","year":"2011","unstructured":"Casian A, Jayne D (2011) Management of alveolar hemorrhage in lung vasculitides. Semin Respir Crit Care Med 32:335\u2013345","journal-title":"Semin Respir Crit Care Med"},{"key":"1419_CR12","first-page":"i37","volume":"30","author":"F Alberici","year":"2015","unstructured":"Alberici F, Martorana D, Vaglio A (2015) Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 30:i37\u2013i45","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons PA, Rayner TF, Trivedi S et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367:214\u2013223","journal-title":"N Engl J Med"},{"key":"1419_CR14","doi-asserted-by":"crossref","unstructured":"Smith RM, Jones RB, Jayne DRW (2012) Progress in treatment of ANCA-associated vasculitis. Arthritis Res Ther 4:210. http:\/\/arthritis-research.com\/content\/14\/2\/210","DOI":"10.1186\/ar3797"},{"key":"1419_CR15","first-page":"i46","volume":"30","author":"U Sch\u00f6nermarck","year":"2015","unstructured":"Sch\u00f6nermarck U, Csernok E, Gross WL (2015) Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014. Nephrol Dial Transplant 30:i46\u2013i52","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR16","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/rheumatology\/ker266","volume":"50","author":"R Suppiah","year":"2011","unstructured":"Suppiah R, Hadden RDM, Batra R et al (2011) Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European vasculitis study group trials. Rheumatology 50:2214\u20132222","journal-title":"Rheumatology"},{"key":"1419_CR17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00480115","volume":"10","author":"M Weiner","year":"2015","unstructured":"Weiner M, Goh SM, Mohammad AJ et al (2015) Outcome and treatment of elderly patients with ANCA-associated vasculitis. Clin J Am Soc Nephrol 10:1128\u20131135","journal-title":"Clin J Am Soc Nephrol"},{"key":"1419_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY et al (1992) Wegener granulomatosis. An analysis of 158 patients. Ann Intern Med 116:448\u2013498","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"1419_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2249.1995.tb06161.x","volume":"101","author":"N Rasmussen","year":"1995","unstructured":"Rasmussen N, Jayne DRW, Abramowicz D et al (1995) European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. Clin Exp Immunol 101(Suppl 1):29\u201334","journal-title":"Clin Exp Immunol"},{"key":"1419_CR20","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfv060","volume":"30","author":"D Jayne","year":"2015","unstructured":"Jayne D, Rasmussen N (2015) Twenty-five years of European Union collaboration in ANCA-associated vasculitis. Nephrol Dial Transplant 30:i1\u2013i7","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D et al (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68:1827\u20131832","journal-title":"Ann Rheum Dis"},{"key":"1419_CR22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann O, Berden A, de Groot K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488\u2013494","journal-title":"Ann Rheum Dis"},{"key":"1419_CR23","doi-asserted-by":"crossref","first-page":"c21","DOI":"10.1159\/000286346","volume":"115","author":"M Itabashi","year":"2010","unstructured":"Itabashi M, Takei T, Yabuki Y et al (2010) Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan. Nephron Clin Pract 115:c21\u2013c27","journal-title":"Nephron Clin Pract"},{"key":"1419_CR24","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/ker112","volume":"50","author":"L Corral-Gudino","year":"2011","unstructured":"Corral-Gudino L, Borao-Cengotita-Bengoa M, del Pino-Montes J, Lerma-M\u00e1rquez JL (2011) Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence. Rheumatology 50:1414\u20131423","journal-title":"Rheumatology"},{"key":"1419_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.ajkd.2007.04.018","volume":"50","author":"F Weidanz","year":"2007","unstructured":"Weidanz F, Day CJ, Hewins P et al (2007) Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis 50:36\u201346","journal-title":"Am J Kidney Dis"},{"key":"1419_CR26","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DRW Jayne","year":"2007","unstructured":"Jayne DRW, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"1419_CR27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.2010.489","volume":"79","author":"AS Bomback","year":"2011","unstructured":"Bomback AS, Appel GB, Radhakrishnan J et al (2011) ANCA-associated glomerulonephritis in the very elderly. Kidney Int 79:757\u2013764","journal-title":"Kidney Int"},{"key":"1419_CR28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s11255-014-0717-y","volume":"46","author":"\u00c1 Haris","year":"2014","unstructured":"Haris \u00c1, Polner K, Ar\u00e1nyi J et al (2014) Clinical outcomes of ANCA-associated vasculitis in elderly patients. Int Urol Nephrol 46:1595\u20131600","journal-title":"Int Urol Nephrol"},{"key":"1419_CR29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ndt\/gfg551","volume":"19","author":"MA Little","year":"2004","unstructured":"Little MA, Nazar L, Farrington K (2004) Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity. Nephrol Dial Transplant 19:356\u2013364","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA et al (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69:1036\u20131043","journal-title":"Ann Rheum Dis"},{"key":"1419_CR31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","volume":"76","author":"S Lionaki","year":"2009","unstructured":"Lionaki S, Hogan SL, Jenette CE et al (2009) The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int 76:644\u2013651","journal-title":"Kidney Int"},{"key":"1419_CR32","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/ndt\/gfu042","volume":"29","author":"Z Hruskova","year":"2014","unstructured":"Hruskova Z, Honsova E, Berden AE et al (2014) Repeat protocol renal biopsy in ANCA-associated renal vasculitis. Nephrol Dial Transplant 29:1728\u20131732","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR33","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1681\/ASN.2005080870","volume":"17","author":"RA de Lind Wijngaarden van","year":"2006","unstructured":"de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264\u20132274","journal-title":"J Am Soc Nephrol"},{"key":"1419_CR34","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1523-1755.1999.00758.x","volume":"56","author":"IM Bajema","year":"1999","unstructured":"Bajema IM, Hagen EC, Hermans J et al (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56:1751\u20131758","journal-title":"Kidney Int"},{"key":"1419_CR35","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ndt\/gfu084","volume":"29","author":"LF Quintana","year":"2014","unstructured":"Quintana LF, Per\u00e9z NS, De Sousa E et al (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 29:1764\u20131769","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR36","doi-asserted-by":"crossref","first-page":"i31","DOI":"10.1093\/ndt\/gfv035","volume":"30","author":"E Daalen van","year":"2015","unstructured":"van Daalen E, Ferrario F, Noel L-H et al (2015) Twenty-five years of RENHIS: a history of histopathological studies within EUVAS. Nephrol Dial Transplant 30:i31\u2013i36","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR37","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628\u20131636","journal-title":"J Am Soc Nephrol"},{"key":"1419_CR38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/qjmed\/hcu043","volume":"107","author":"M Romeu","year":"2014","unstructured":"Romeu M, Couchoud C, Delarozi\u00e9re J-C et al (2014) Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011. Q J Med 107:545\u2013555","journal-title":"Q J Med"},{"key":"1419_CR39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2015.03.025","volume":"66","author":"Z Hruskova","year":"2015","unstructured":"Hruskova Z, Stel VS, Jayne D et al (2015) Characteristics and outcome of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European Renal Association\u2013European Dialysis and Transplant Association Registry. Am J Kidney Dis 66:613\u2013620","journal-title":"Am J Kidney Dis"},{"key":"1419_CR40","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","volume":"58","author":"C Pagnoux","year":"2008","unstructured":"Pagnoux C, Hogan SL, Chin H et al (2008) Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Arthritis Rheum 58:2908\u20132918","journal-title":"Arthritis Rheum"},{"key":"1419_CR41","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/rheumatology\/keq244","volume":"49","author":"CP-D Despujol","year":"2010","unstructured":"Despujol CP-D, Pouchot J, Pagnoux C et al (2010) Predictors at diagnosis of a first Wegener\u2019s granulomatosis relapse after obtaining complete remission. Rheumatology 49:2181\u20132190","journal-title":"Rheumatology"},{"key":"1419_CR42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","volume":"64","author":"M Walsh","year":"2012","unstructured":"Walsh M, Flossmann O, Berden A et al (2012) Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64:542\u2013548","journal-title":"Arthritis Rheum"},{"key":"1419_CR43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","volume":"71","author":"L Harper","year":"2102","unstructured":"Harper L, Morgan MD, Walsh M et al (2102) Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis 71:955\u2013960","journal-title":"Ann Rheum Dis"},{"key":"1419_CR44","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/ndt\/gfq523","volume":"26","author":"JL Merino","year":"2011","unstructured":"Merino JL, Galeano C, Espejo B et al (2011) A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy. Nephrol Dial Transplant 26:1360\u20131366","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR45","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/art.38044","volume":"65","author":"EM Miloslavsky","year":"2013","unstructured":"Miloslavsky EM, Specks U, Merkel PA et al (2013) Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 65:2441\u20132449","journal-title":"Arthritis Rheum"},{"key":"1419_CR46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11926-014-0430-y","volume":"16","author":"L Guillevin","year":"2014","unstructured":"Guillevin L (2014) Treatment of severe and\/or refractory ANCA-associated vasculitis. Curr Rheumatol Rep 16:430","journal-title":"Curr Rheumatol Rep"},{"key":"1419_CR47","doi-asserted-by":"publisher","unstructured":"(2012) Chapter 13: Pauci-immune focal and segmental necrotizing glomerulonephritis. Kidney Int Suppl 2(2): 233\u2013239. doi: 10.1038\/kisup.2012.26","DOI":"10.1038\/kisup.2012.26"},{"key":"1419_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209133","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM et al (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2016-209133","journal-title":"Ann Rheum Dis"},{"key":"1419_CR49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"AS Fauci","year":"1983","unstructured":"Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21\u00a0years. Ann Intern Med 98:76\u201385","journal-title":"Ann Intern Med"},{"key":"1419_CR50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K Groot de","year":"2009","unstructured":"de Groot K, Harper L, Jayne DRW et al (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med 150:670\u2013680","journal-title":"Ann Intern Med"},{"key":"1419_CR51","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.30296","volume":"63","author":"G Le Guenno","year":"2011","unstructured":"Le Guenno G, Mahr A, Pagnoux C, Dhote R, Guillevin L; French Vasculitis Study Group et al (2011) Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis Rheum 63:1435\u20131445","journal-title":"Arthritis Rheum"},{"key":"1419_CR52","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","volume":"57","author":"M Walsh","year":"2011","unstructured":"Walsh M, Catapano F, Szpirt W et al (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57:566\u2013574","journal-title":"Am J Kidney Dis"},{"key":"1419_CR53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2215\/CJN.03680412","volume":"8","author":"RJ Pepper","year":"2013","unstructured":"Pepper RJ, Chanouzas D, Tarzi R et al (2013) Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis. Clin J Am Soc Nephrol 8:219\u2013224","journal-title":"Clin J Am Soc Nephrol"},{"key":"1419_CR54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","volume":"84","author":"M Walsh","year":"2013","unstructured":"Walsh M, Casian A, Flossmann O et al (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84:397\u2013402","journal-title":"Kidney Int"},{"key":"1419_CR55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ndt\/gfq360","volume":"26","author":"WM Szpirt","year":"2011","unstructured":"Szpirt WM, Heaf JG, Petersen J (2011) Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener\u2019s granulomatosis \u2013 a clinical randomized controlled trial. Nephrol Dial Transplant 26:206\u2013213","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 70","key":"1419_CR56","first-page":"S39","volume":"30","author":"JW Gregensen","year":"2012","unstructured":"Gregensen JW, Kristensen T, Krag SRP et al (2012) Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis. Clin Exp Rheumatol 30(Suppl 70):S39\u2013S47","journal-title":"Clin Exp Rheumatol"},{"key":"1419_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-14-73","author":"M Walsh","year":"2013","unstructured":"Walsh M, Merkel PA, Peh CA et al (2013) Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. BioMed Cent. doi: 10.1186\/1745-6215-14-73","journal-title":"BioMed Cent"},{"key":"1419_CR58","first-page":"i150","volume":"30","author":"AAE Joode de","year":"2015","unstructured":"de Joode AAE, Sanders JSF, Rutgers A, Stegeman CA (2015) Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long? Nephrol Dial Transplant 30:i150\u2013i158","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR59","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","volume":"62","author":"M Walsh","year":"2010","unstructured":"Walsh M, Merkel PA, Mahr A, Jayne D (2010) The effects of duration of glucocorticoid therapy on relapse rate in anti-neutrophil cytoplasm antibody associated vasculitis: a meta-analysis. Arthritis Care Res 62:1166\u20131173","journal-title":"Arthritis Care Res"},{"key":"1419_CR60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"1419_CR61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"1419_CR62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","volume":"369","author":"U Specks","year":"2013","unstructured":"Specks U, Merkel PA, Seo P et al (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369:417\u2013427","journal-title":"N Engl J Med"},{"key":"1419_CR63","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/rheumatology\/ket257","volume":"52","author":"E Besada","year":"2013","unstructured":"Besada E, Koldingsnes W, Nossent JC (2013) Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre. Rheumatology 52:2041\u20132047","journal-title":"Rheumatology"},{"key":"1419_CR64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JWC, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"1419_CR65","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/ket381","volume":"53","author":"P Charles","year":"2014","unstructured":"Charles P, N\u00e9el A, Tieuli\u00e9 N et al (2014) Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheumatology 53:532\u2013539","journal-title":"Rheumatology"},{"key":"1419_CR66","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/rheumatology\/ker150","volume":"51","author":"M-JCJ Guerry","year":"2012","unstructured":"Guerry M-JCJ, Brogan P, Bruce IN et al (2012) Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology 51:634\u2013643","journal-title":"Rheumatology"},{"key":"1419_CR67","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A et al (2014) Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 371:1771\u20131780","journal-title":"N Engl J Med"},{"key":"1419_CR68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/ndt\/gfv216","volume":"30","author":"A Kronbichler","year":"2015","unstructured":"Kronbichler A, Jayne DRW (2015) Con: should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant 30:1075\u20131081","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR69","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfv217","volume":"30","author":"U Specks","year":"2015","unstructured":"Specks U (2015) Pro: should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant 30:1083\u20131087","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR70","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ndt\/gfv215","volume":"30","author":"V Tesar","year":"2015","unstructured":"Tesar V (2015) Moderator\u2019s view: should all patients with ANCA-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant 30:1088\u20131090","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR71","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/08916934.2012.677078","volume":"45","author":"M Szilasi","year":"2012","unstructured":"Szilasi M, M\u00e1tyus J, File I et al (2012) Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice? Autoimmunity 45:304\u2013309","journal-title":"Autoimmunity"},{"key":"1419_CR72","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","volume":"304","author":"TF Hiemstra","year":"2010","unstructured":"Hiemstra TF, Walsh M, Mahr A et al (2010) Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis. JAMA 304:2381\u20132388","journal-title":"JAMA"},{"key":"1419_CR73","doi-asserted-by":"crossref","first-page":"i132","DOI":"10.1093\/ndt\/gfv061","volume":"30","author":"J Draibe","year":"2015","unstructured":"Draibe J, Poveda R, Fulladosa X et al (2015) Use of mycophenolate in ANCA-associated renal vasculitis: 13\u00a0years of experience at a university hospital. Nephrol Dial Transplant 30:i132\u2013i137","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR74","doi-asserted-by":"crossref","first-page":"i138","DOI":"10.1093\/ndt\/gfv065","volume":"30","author":"M Schaier","year":"2015","unstructured":"Schaier M, Scholl C, Scharpf D et al (2015) High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 30:i138\u2013i145","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"DRW Jayne","year":"2000","unstructured":"Jayne DRW, Chapel H, Adu D et al (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Q J Med 93:433\u2013439","journal-title":"Q J Med"},{"key":"1419_CR76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/rheumatology\/kep411","volume":"49","author":"O Flossmann","year":"2010","unstructured":"Flossmann O, Jayne DRW (2010) Long-term treatment of relapsing Wegener\u2019s granulomatosis with 15-deoxyspergualin. Rheumatology 49:556\u2013562","journal-title":"Rheumatology"},{"key":"1419_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOR.0000000000000005","volume":"26","author":"S Furuta","year":"2014","unstructured":"Furuta S, Jayne D (2014) Emerging therapies in antineutrophil cytoplasm antibody-associated vasculitis. Curr Opin Rheumatol 26:1\u20136","journal-title":"Curr Opin Rheumatol"},{"key":"1419_CR78","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2215\/CJN.05610611","volume":"7","author":"JG McGregor","year":"2012","unstructured":"McGregor JG, Hogan SL, Hu Y et al (2012) Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol 7:240\u2013247","journal-title":"Clin J Am Soc Nephrol"},{"key":"1419_CR79","doi-asserted-by":"crossref","first-page":"i123","DOI":"10.1093\/ndt\/gfv076","volume":"30","author":"JG McGregor","year":"2015","unstructured":"McGregor JG, Hogan SL, Kotzen ES et al (2015) Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 30:i123\u2013i131","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR80","doi-asserted-by":"crossref","first-page":"i171","DOI":"10.1093\/ndt\/gfv045","volume":"30","author":"JG McGregor","year":"2015","unstructured":"McGregor JG, Negrete-Lopez R, Poulton CJ et al (2015) Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrol Dial Transplant 30:i171\u2013i181","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR81","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.2008.088302","volume":"68","author":"C Charlier","year":"2009","unstructured":"Charlier C, Henegar C, Launay O et al (2009) Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis 68:658\u2013663","journal-title":"Ann Rheum Dis"},{"key":"1419_CR82","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard.2010.145250","volume":"70","author":"C Heijl","year":"2011","unstructured":"Heijl C, Harpel L, Flossmann O et al (2011) Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European vasculitis study group clinical trials. Ann Rheum Dis 70:1415\u20131421","journal-title":"Ann Rheum Dis"},{"key":"1419_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126016","author":"W Shang","year":"2015","unstructured":"Shang W, Ning Y, Xu X et al (2015) Incidence of cancer in ANCA-associated vasculitis: a meta-analysis of observational studies. PLoS One. doi: 10.1371\/journal.pone.0126016","journal-title":"PLoS One"},{"key":"1419_CR84","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/rheumatology\/keu372","volume":"54","author":"M Faurschou","year":"2015","unstructured":"Faurschou M, Mellemkjaer L, Voss A et al (2015) Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis. Rheumatology 54:1345\u20131350","journal-title":"Rheumatology"},{"key":"1419_CR85","first-page":"2571","volume":"29","author":"DLT Huong","year":"2002","unstructured":"Huong DLT, Amoura Z, Duhaut P et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29:2571\u20132576","journal-title":"J Rheumatol"},{"key":"1419_CR86","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000368569","volume":"128","author":"V Tesar","year":"2014","unstructured":"Tesar V, Hruskova Z (2014) Limitations of standard immunosuppressive treatment in ANCA-associated vasculitis and lupus nephritis. Nephron Clin Pract 128:205\u2013215","journal-title":"Nephron Clin Pract"},{"key":"1419_CR87","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/keq421","volume":"50","author":"C Pagnoux","year":"2011","unstructured":"Pagnoux C, Guern VL, Goffinet F et al (2011) Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies. Rheumatology 50:953\u2013961","journal-title":"Rheumatology"},{"key":"1419_CR88","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/acr.21556","volume":"64","author":"J Tuin","year":"2012","unstructured":"Tuin J, Sanders JSF, de Joode AAE, Stegeman CA (2012) Pregnancy in women diagnosed with antineutrophil cytoplasmic antibody-associated vasculitis: outcome for the mother and the child. Arthritis Care Res 64:539\u2013545","journal-title":"Arthritis Care Res"},{"issue":"Suppl. 52","key":"1419_CR89","first-page":"S86","volume":"27","author":"F Alfhaily","year":"2009","unstructured":"Alfhaily F, Watts R, Leather A (2009) Wegener\u2019s granulomatosis occurring de novo during pregnancy. Clin Exp Rheumatol 27(Suppl. 52):S86\u2013S88","journal-title":"Clin Exp Rheumatol"},{"key":"1419_CR90","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1046\/j.1523-1755.1999.00666.x","volume":"56","author":"PH Nachman","year":"1999","unstructured":"Nachman PH, Segelmark M, Westman K et al (1999) Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 56:1544\u20131550","journal-title":"Kidney Int"},{"key":"1419_CR91","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/TP.0b013e31821ab9aa","volume":"91","author":"D Geetha","year":"2011","unstructured":"Geetha D, Eirin A, True K et al (2011) Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience. Transplantation 91:1370\u20131375","journal-title":"Transplantation"},{"key":"1419_CR92","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/ndt\/gfp347","volume":"24","author":"MA Little","year":"2009","unstructured":"Little MA, Hassan B, Jacques S et al (2009) Renal transplantation in systemic vasculitis: when is it safe? Nephrol Dial Transplant 24:3219\u20133225","journal-title":"Nephrol Dial Transplant"},{"key":"1419_CR93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/BOR.0000000000000006","volume":"26","author":"S Moran","year":"2014","unstructured":"Moran S, Little MA (2014) Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Rheumatol 26:37\u201341","journal-title":"Curr Opin Rheumatol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-016-1419-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T05:23:06Z","timestamp":1657344186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-016-1419-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s11255-016-1419-4","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,26]]}}}